Document Detail

Novel paths towards neural cellular products for neurological disorders.
MedLine Citation:
PMID:  21999259     Owner:  NLM     Status:  In-Data-Review    
The prospect of using neural cells derived from stem cells or from reprogrammed adult somatic cells provides a unique opportunity in cell therapy and drug discovery for developing novel strategies for brain repair. Cell-based therapeutic approaches for treating CNS afflictions caused by disease or injury aim to promote structural repair of the injured or diseased neural tissue, an outcome currently not achieved by drug therapy. Preclinical research in animal models of various diseases or injuries report that grafts of neural cells enhance endogenous repair, provide neurotrophic support to neurons undergoing degeneration and replace lost neural cells. In recent years, the sources of neural cells for treating neurological disorders have been rapidly expanding and in addition to offering therapeutic potential, neural cell products hold promise for disease modeling and drug discovery use. Specific neural cell types have been derived from adult or fetal brain, from human embryonic stem cells, from induced pluripotent stem cells and directly transdifferentiated from adult somatic cells, such as skin cells. It is yet to be determined if the latter approach will evolve into a paradigm shift in the fields of stem cell research and regenerative medicine. These multiple sources of neural cells cover a wide spectrum of safety that needs to be balanced with efficacy to determine the viability of the cellular product. In this article, we will review novel sources of neural cells and discuss current obstacles to developing them into viable cellular products for treating neurological disorders.
Marcel M Daadi
Related Documents :
21707709 - In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
21526269 - Toxicity mechanisms of onion (allium cepa) extracts and compounds in multidrug resistan...
21810539 - Intracellular dynamics of cationic and anionic polystyrene nanoparticles without direct...
21636699 - Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase i inhibi...
21721029 - Intercellular nanovesicle-mediated microrna transfer: a mechanism of environmental modu...
21573619 - Modulation of y-79 retinoblastoma cell-differentiation and irbp expression by dibutyryl...
11319029 - Cks1at overexpression in arabidopsis thaliana inhibits growth by reducing meristem size...
6734569 - Cadmium uptake and metabolism in cultured cells.
22990129 - Differential molecular mechanism of docetaxel-octreotide combined treatment according t...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Regenerative medicine     Volume:  6     ISSN:  1746-076X     ISO Abbreviation:  Regen Med     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278116     Medline TA:  Regen Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  25-30     Citation Subset:  IM    
Program in Stem Cell & Regenerative Biology, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA; Department of Neurosurgery, Stanford Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Stanford, CA 94305 USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stem cell therapy in cardiology.
Next Document:  In vivo manipulation of stem cells for adipose tissue repair/reconstruction.